Healthy hearing available to all
Akouos is a precision genetic medicine company developing gene therapies to restore, improve, and preserve high-acuity physiologic hearing for people with disabling hearing loss. Focused on inner ear delivery and AAV gene therapy platforms, it was acquired by Eli Lilly. Targets genetic forms of hearing loss affecting 466 million worldwide.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.